Filter
366
Text search:
Antimalarial
treatment
policy
Featured
Recommendations
39
New Publications
173
Language
Document type
No document type
263
Studies & Reports
40
Guidelines
29
Manuals
9
Fact sheets
9
Training Material
7
Strategic & Response Plan
7
Situation Updates
2
Countries / Regions
Uganda
23
Kenya
19
Liberia
16
Ghana
15
India
15
Malawi
15
Sierra Leone
14
Nigeria
13
Tanzania
12
Global
12
Zambia
11
Ethiopia
10
Rwanda
10
Zimbabwe
7
Senegal
6
Namibia
6
Nepal
5
Mozambique
5
Cameroon
4
Cambodia
4
Bangladesh
4
South–East Asia Region
4
Africa
4
Philippines
3
Indonesia
3
Eswatini/ Swaziland
3
Myanmar / Burma
3
West and Central Africa
3
Burkina Faso
2
Congo, Democratic Republic of
2
Somalia
2
South Sudan
2
Thailand
2
South Africa
2
Botswana
2
Madagascar
2
East and Southern Africa
2
Latin America and the Carribbean
2
Paraguay
2
Venezuela
2
Guinea
1
Mali
1
Haiti
1
Pakistan
1
Lebanon
1
Sudan
1
Benin
1
Libya
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Southern Africa
1
Laos
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
238
Clinical Guidelines
48
Women & Child Health
25
Public Health
17
Pharmacy & Technologies
8
Capacity Building
6
Key Resources
5
Toolboxes
Pharmacy
17
AMR
16
Ebola
8
HIV
8
COVID-19
6
Rapid Response
4
Caregiver
4
NTDs
4
Conflict
3
Mental Health
3
TB
2
Planetary Health
2
Health Financing Toolbox
2
Cholera
1
Global Health Education
1
Interagency Guidelines - This revised Interagency List of Essential Medicines for Reproductive Health presents
the current international consensus on rational selection of essential reproductive health medicines. The list is intended to support decisions regarding the production, quality assurance
...
The government of Rwanda conducted the 2010 Rwanda Demographic and Health Survey (RDHS) to gather up-to-date information for monitoring progress on healthcare programs and policies in Rwanda, including the Economic Development and Poverty Reduction Strategy (EDPRS), the Millennium Development Goals
...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...
The Integrated Management of Adolescent/Adult Illness (IMAI) approach
Prices people pay for medicines.
